PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 114 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $22,000 | +10.0% | 4,139 | 0.0% | 0.00% | – |
| Q4 2018 | $20,000 | -50.0% | 4,139 | 0.0% | 0.00% | – |
| Q3 2018 | $40,000 | -4.8% | 4,139 | 0.0% | 0.00% | – |
| Q2 2018 | $42,000 | -22.2% | 4,139 | 0.0% | 0.00% | – |
| Q1 2018 | $54,000 | -27.0% | 4,139 | 0.0% | 0.00% | – |
| Q4 2017 | $74,000 | -28.8% | 4,139 | 0.0% | 0.00% | – |
| Q3 2017 | $104,000 | +100.0% | 4,139 | +110.1% | 0.00% | – |
| Q2 2015 | $52,000 | – | 1,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |